Drugs that are used to cure different ailments have often been found to contain cancer-treating elements. In another such development, new research has shown that combining the treatment for the most deadly form of skin cancer with a common anti-rheumatic drug could provide more effective results. Many times, chemotherapy drugs don't reach the cancer cells because of which patients don't respond well to the treatment.
The findings showed that using "leflunomide" – an immunosuppressive drug approved for treatment of rheumatoid arthritis – in combination with another melanoma drug, selumetinib almost completely stopped the growth of a melanoma tumour in mice. "By combining therapies, it's possible to attack the disease from several angles, which makes it harder for the melanoma to develop resistance to any of the drugs," said Grant Wheeler from the University of East Anglia (UEA) in the…
